Keyphrases
Metastatic Melanoma
100%
Stress Conditions
100%
Basal Autophagy
100%
BRAF V600E
100%
Apoptotic Resistance
100%
Chronic ER Stress
100%
Stress Status
75%
Tumor
50%
Therapeutic Strategies
50%
Melanoma
50%
Targeted Therapy
50%
Endoplasmic Reticulum Stress (ER stress)
50%
Chemoresistance
50%
TRB3
50%
Apoptosis
25%
Melanoma Cells
25%
Basal Cell
25%
Increased Incidence
25%
Current Treatment
25%
Treatment Strategy
25%
Unresponsiveness
25%
Mammalian Target of Rapamycin (mTOR)
25%
Autophagy
25%
Beclin-1
25%
Autophagic Activity
25%
Cell Autophagy
25%
Clinical Problems
25%
Recent Advances
25%
Bcl-xL
25%
P38 Activation
25%
Acquired Resistance
25%
BRAF V600E mutant
25%
Apoptosis Signal-regulating Kinase 1 (ASK1)
25%
Chemical Chaperone
25%
Bcl-2 Phosphorylation
25%
Inositol-requiring Enzyme 1 (IRE1)
25%
BRAF-mutant Melanoma
25%
Melanoma Development
25%
Medicine and Dentistry
Carcinogenesis
100%
Autophagy
100%
Endoplasmic Reticulum Stress
100%
Melanoma Skin Cancer
100%
Melanoma
66%
Neoplasm
33%
Drug Resistance
33%
Targeted Therapy
33%
Programmed Cell Death
16%
Clinical Study
16%
Basal Cell
16%
Melanoma Cell
16%
Beclin 1
16%
Chaperone
16%
Protein Kinase B
16%
Pharmacology, Toxicology and Pharmaceutical Science
Melanoma
100%
Carcinogenesis
100%
Cutaneous Melanoma
100%
Neoplasm
40%
Drug Resistance
40%
Beclin 1
20%
Preclinical Study
20%
Chaperone
20%
Biochemistry, Genetics and Molecular Biology
Carcinogenesis
100%
Autophagy
100%
Endoplasmic Reticulum Stress
100%
Drug Resistance
33%
Preclinical Study
16%
Bcl-2
16%
ASK1
16%
Chemical Chaperone
16%
Programmed Cell Death
16%
Protein Kinase B
16%
Immunology and Microbiology
Autophagy
100%
Endoplasmic Reticulum Stress
100%
Drug Resistance
33%
Basal Cell
16%
Melanoma Cell
16%
Bcl-2
16%
Preclinical Study
16%
ASK1
16%
Programmed Cell Death
16%